HIF1A Identified as Potential Target for Treating Myelodysplastic Syndromes

Researchers at the  Cincinnati Children's Hospital Medical Center  say they have identified a gene in laboratory experiments that fuels the biological processes that cause the different types of myelodysplastic syndromes (MDS) that physicians see in patients. MDS is linked to a number of different gene mutations and is considered one of the most complex malignancies affecting blood-making hematopoietic stem cells in bone marrow. These blood disorders cause peop